Journal article

The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern

T Prasanna, CS Karapetis, D Roder, J Tie, R Padbury, T Price, R Wong, J Shapiro, L Nott, M Lee, YJ Chua, P Craft, C Piantadosi, M Sorich, P Gibbs, D Yip

Acta Oncologica | TAYLOR & FRANCIS LTD | Published : 2018

Open access

Abstract

Background: Pattern of spread in patients with metastatic colorectal cancer (mCRC) is variable and may reflect different biology in subsets of patients. This is a retrospective study to explore the outcome of patients with mCRC based on their site of metastasis at diagnosis and to explore the association between tumor characteristics [KRAS/RAS, BRAF, mismatch repair (MMR) status, site of primary] and the site of metastasis. Methods: Patients from two Australian databases were divided into six groups based on site of metastasis at time of diagnosis of metastatic disease; lung-only, liver-only, lymph node-only or any patients with brain, bone or peritoneal metastases. Primary endpoint was over..

View full abstract

University of Melbourne Researchers

Grants

Funding Acknowledgements

Roche Products Pty Limited has provided financial assistance for the development, installation and maintenance of the BioGrid-TRACC registry. The South Australian State Government has provided support for the maintenance of the SA Metastatic Colorectal Cancer Registry. All authors listed have made substantial, direct and intellectual contribution in the design, acquisition of data, conduct, writing and editing of this article.